Ly, Sophia
Reyes-Hadsall, Sophia
Drake, Lara
Zhou, Guohai
Nelson, Caroline
Barbieri, John S.
Mostaghimi, Arash http://orcid.org/0000-0002-6084-5617
Article History
Received: 6 July 2023
Accepted: 7 September 2023
First Online: 22 September 2023
Declarations
:
: Arash Mostaghimi declares financial interest and a position on the advisory board of Fig. 1 Beauty, Inc., Eli Lilly and Company, Pfizer Inc., and Hims. AM receives fees as a consultant from AbbVie, Concert Pharmaceuticals, Pfizer Inc., and 3Derm Systems. AM is the founder of Lucid, Inc., and receives research funding from Incyte Corporation, AclarisTherapeutics Inc., Eli Lilly and Company, and Concert Pharmaceuticals. All other authors have no conflicts of interest to declare.
: Study approval was received from the Mass General Brigham Institutional Review Board (protocol number: 2022P000911). Ethics committee approval was not required. The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All subjects provided informed consent to participate in the study.